(2018) COMPARE CPM-RMI Trial: Intramyocardial Transplantation of Autologous Bone Marrow-Derived CD133(+) Cells and MNCs during CABG in Patients with Recent MI: A Phase II/III, Multicenter, Placebo-Controlled, Randomized, Double-Blind Clinical Trial. Cell Journal. pp. 267-277. ISSN 2228-5806

(2018) Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. pp. 499-506. ISSN 1465-3249

(2013) PHASE III RANDOMIZED CLINICAL TRIAL COMPARING THE EFFECTS OF AUTOLOGOUS BONE MARROW DERIVED MNC AND CD133 CELLS TRANSPLANTATION IN AMI PATIENTS DURING CABG. Cytotherapy. S12-S12. ISSN 1465-3249